A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So CYCLONE 2 was a study looking at ...

Gen-Probe acquired the exclusive global rights to the PCA3 (a genetic marker for prostate cancer) from Canadian cancer diagnostic tests company DiagnoCure in November 2003.

WASHINGTON (Reuters) - U.S. regulators are investigating potential risks from Abbott Laboratories Inc's HIV drug Kaletra, GlaxoSmithKline Plc's prostate drug Avodart and other medicines. The Food and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In this video, Alexander Chehrazi-Raffle, ...